Mitochondria as a therapeutic target for aging and neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Alzheimer Research

• Publication date

  2011-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156720511795745401PMID 21470101PMCID PMC3295247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• Huntington's disease in children.

  2013cited by this paper
• The Merck manual of Health and Aging

  2012cited by this paper
• Mitochondrial Dysfunction in Parkinson's Disease

  2011cited by this paper
• Mitochondrial Amyloid-β Levels are Associated with the Extent of Mitochondrial Dysfunction in Different Brain Regions and the Degree of Cognitive Impairment in Alzheimer's Transgenic Mice

  2010influential reference
• Unlocking the Door to Neuronal Woes in Alzheimer’s Disease: Aβ and Mitochondrial Permeability Transition Pore

  2010cited by this paper
• The Alzheimer's Disease Mitochondrial Cascade Hypothesis

  2010cited by this paper
• ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2

  2010cited by this paper
• Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila

  2010cited by this paper
• Mitochondria-Targeted Antioxidants Protect Against Amyloid-β Toxicity in Alzheimer's Disease Neurons

  2010influential reference
• Mitochondrial therapies for Parkinson's disease

  2010cited by this paper
• Systemic Mitochondrial Dysfunction and the Etiology of Alzheimer's Disease and Down Syndrome Dementia

  2010influential reference
• Linking functional decline of telomeres, mitochondria and stem cells during ageing

  2010cited by this paper
• Neural mechanisms of ageing and cognitive decline

  2010cited by this paper
• Age-related increase in mitochondrial DNA damage and loss of DNA repair capacity in the neural retina.

  2010cited by this paper
• Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

  2010cited by this paper
• Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

  2010cited by this paper
• Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Extending Healthy Life Span—From Yeast to Humans

  2010cited by this paper
• ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions

  2010cited by this paper
• Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline

  2010cited by this paper
• The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

  2010cited by this paper
• Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.

  2010cited by this paper
• Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

  2010cited by this paper
• Mitochondrial Dysfunction in Parkinson's Disease

  2010cited by this paper
• Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound

  2010cited by this paper
• Mitochondrial Dysfunction is a Converging Point of Multiple Pathological Pathways in Amyotrophic Lateral Sclerosis

  2010cited by this paper
• DNA damage, aging, and cancer.

  2009cited by this paper
• In Situ Mitochondrial Ca2+ Buffering Differences of Intact Neurons and Astrocytes from Cortex and Striatum*

  2009cited by this paper
• Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets

  2009cited by this paper
• Mitochondrial structural and functional dynamics in Huntington's disease.

  2009cited by this paper
• Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

  2009cited by this paper
• Oxidative stress sensitivity in ALS muscle cells.

  2009cited by this paper
• Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies

  2009cited by this paper
• Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

  2009cited by this paper
• The Alzheimer's disease mitochondrial cascade hypothesis: an update.

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

  2009cited by this paper
• Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission*

  2009cited by this paper
• Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

  2009influential reference
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

  2009cited by this paper
• Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

  2008cited by this paper
• Mitochondrial Medicine for Aging and Neurodegenerative Diseases

  2008influential reference
• N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

  2008cited by this paper
• Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

  2008cited by this paper
• Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

  2008cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

  2008cited by this paper
• Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells.

  2008cited by this paper
• Mitochondrial disorders in the nervous system.

  2008cited by this paper
• The PINK1/Parkin pathway regulates mitochondrial morphology

  2008cited by this paper
• Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

  2008cited by this paper
• Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats*

  2008cited by this paper
• The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila

  2008cited by this paper
• Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain*

  2008cited by this paper
• Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases

  2008cited by this paper
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

  2008influential reference
• Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease*

  2008cited by this paper
• Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism

  2008cited by this paper
• Mitochondrial association of alpha-synuclein causes oxidative stress

  2008cited by this paper
• Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease

  2007cited by this paper
• Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.

  2007cited by this paper
• Mitochondrial Sensitivity and Altered Calcium Handling Underlie Enhanced NMDA-Induced Apoptosis in YAC128 Model of Huntington's Disease

  2007cited by this paper
• Mitochondrial dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice

  2007cited by this paper
• Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.

  2007cited by this paper
• Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

  2007cited by this paper
• Parkinson's disease.

  2007cited by this paper
• Mitochondrial Dysfunction in Aging and Alzheimer's Disease: Strategies to Protect Neurons

  2007influential reference
• Huntington’s Disease and Mitochondrial DNA Deletions: Event or Regular Mechanism for Mutant Huntingtin Protein and CAG Repeats Expansion?!

  2007cited by this paper
• Mitochondrial NAD+‐linked State 3 respiration and complex‐I activity are compromised in the cerebral cortex of 3‐nitropropionic acid‐induced rat model of Huntington’s disease

  2007cited by this paper
• Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin

  2007cited by this paper
• Trinucleotide repeat disorders.

  2007cited by this paper
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Mitochondriopathy in Parkinson Disease and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

  2006cited by this paper
• Mitochondrial dysfunction and amyotrophic lateral sclerosis

  2006cited by this paper
• Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors

  2006cited by this paper
• Neuronal protection by sirtuins in Alzheimer's disease

  2006cited by this paper
• Human Genome & Diseases: Review Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies

  2006cited by this paper
• Overloading of Stable and Exclusion of Unstable Human Superoxide Dismutase-1 Variants in Mitochondria of Murine Amyotrophic Lateral Sclerosis Models

  2006cited by this paper
• Multiple pathways contribute to the pathogenesis of Huntington disease

  2006cited by this paper
• Huntingtin inhibits caspase‐3 activation

  2006cited by this paper
• Brain imaging and cognitive dysfunctions in Huntington's disease.

  2006cited by this paper
• Parkinsonism genes: culprits and clues

  2006cited by this paper
• Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.

  2006cited by this paper
• Mitochondrial fusion and fission in mammals.

  2006cited by this paper
• Oxidative Damage in Huntington's Disease Pathogenesis

  2006cited by this paper
• Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III.

  2006cited by this paper
• Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.

  2006cited by this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cited by this paper
• Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease

  2006cited by this paper
• Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells

  2006cited by this paper
• Resveratrol--a boon for treating Alzheimer's disease?

  2006cited by this paper
• Faculty Opinions recommendation of Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.

  2006cited by this paper
• Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington’s disease individuals

  2005cited by this paper
• Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction

  2005cited by this paper
• Are mitochondria critical in the pathogenesis of Alzheimer's disease?

  2005cited by this paper

• Autophagy activation by taurine alleviates prion-induced mitochondrial dysfunction and neurotoxicity.

  2026cites this paper
• Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterations

  2026cites this paper
• Impact of Diet and Exercise on Mitochondrial Quality and Mitophagy in Alzheimer's disease.

  2025cites this paper
• Selenium improves behavioral performance in a rat model of autism spectrum disorder by mitigating oxidative stress and modulating the Sirt1/Keap1/Nrf2/HO-1 signaling pathway.

  2025cites this paper
• The role of mitochondrial remodeling in neurodegenerative diseases.

  2025cites this paper
• Therapeutic modulation of mitochondrial dynamics by agmatine in neurodegenerative disorders.

  2025cites this paper
• Polyphenols and Exercise in Mitochondrial Biogenesis: Focus on Age-Related CNS Disorders

  2025cites this paper
• Exercise-Induced Neuroplasticity: Adaptive Mechanisms and Preventive Potential in Neurodegenerative Disorders

  2025cites this paper
• Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2025cites this paper
• Brain-Resident Immune Cells in Neurodevelopmental Disorders.

  2025cites this paper
• Oxidative Stress and Mitochondrial Impairment: Key Drivers in Neurodegenerative Disorders.

  2025cites this paper
• The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective

  2025cites this paper
• Therapeutic potential of DDQ in enhancing mitochondrial health and cognitive function in Late-Onset Alzheimer's disease.

  2025cites this paper
• Histone deacetylase's regulates Tau function in Alzheimer's disease.

  2025cites this paper
• Neurocognitive correlates of cerebral mitochondrial function and energy metabolism using phosphorus magnetic resonance spectroscopy in older adults

  2024cites this paper
• SuperAgers and Centenarians, Dynamics of Healthy Ageing with Cognitive Resilience.

  2024cites this paper
• Engineered Mitochondrial Transplantation as An Anti-Aging Therapy

  2024cites this paper
• Anti-Aging Potential of Bioactive Phytoconstituents Found in Edible Medicinal Plants: A Review

  2024cites this paper
• Inflammatory Signaling Induces Mitochondrial Dysfunction and Neuronal Death in Traumatic Brain Injury via Downregulation of OXPHOS Genes

  2024cites this paper
• Androcin 18-1, a novel scorpion-venom peptide, shows a potent antitumor activity against human U87 cells via inducing mitochondrial dysfunction.

  2024cites this paper
• Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions.

  2024cites this paper
• Role of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity

  2024cites this paper
• PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration

  2024cites this paper
• Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population

  2024cites this paper
• Ferroptosis, M6A and immune checkpoint-related gene expression in the middle temporal gyrus of the Alzheimer’s disease brain

  2024cites this paper
• the Improvement Effects of Sika Deer Antler Protein in an Alzheimer's Disease Mouse Model via the Microbe–Gut–Brain Axis

  2024cites this paper
• A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.

  2023cites this paper
• MITOCHONDRIAL BIOENERGETICS AND CYTOMETRIC CHARACTERIZATION OF A SYNAPTOSOMAL PREPARATION FROM MOUSE BRAIN CORTEX.

  2023cites this paper
• Fibrinogen in mice cerebral microvessels induces blood–brain barrier dysregulation with aging via a dynamin-related protein 1–dependent pathway

  2023cites this paper
• Saponins from Panax japonicus improve neuronal mitochondrial injury of aging rats

  2023cites this paper
• Transfusion with Blood Plasma from Young Mice Affects rTg4510 Transgenic Tau Mice Modeling of Alzheimer’s Disease

  2023cites this paper
• Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies

  2023cites this paper
• Cellular and Mitochondrial NAD Homeostasis in Health and Disease

  2023cites this paper
• Micronutrients/miRs/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden.

  2023cites this paper
• Alleviation of behavioral deficits, amyloid-β deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.

  2023cites this paper
• Targeted to neuronal organelles for CNS drug development.

  2023cites this paper
• Modulating Cytotoxicity with Lego-like Chemistry: Upgrading Mitochondriotropic Antioxidants with Prototypical Cationic Carrier Bricks.

  2023cites this paper
• Content CN-21-5

  2023cites this paper
• Regulation of mitochondrial function by forkhead transcription factors.

  2022cites this paper
• Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects

  2022cites this paper
• Preventing Axonal Sodium Overload or Mitochondrial Calcium Uptake Protects Axonal Mitochondria from Oxidative Stress-Induced Alterations

  2022cites this paper
• Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease Using Conjugates of Serotonin with Sesquiterpene Lactones.

  2022cites this paper
• The Effect of Astaxanthin on the Functional State of Brain Mitochondria in Rats with Heart Failure

  2022cites this paper
• Smp24, a Scorpion-Venom Peptide, Exhibits Potent Antitumor Effects against Hepatoma HepG2 Cells via Multi-Mechanisms In Vivo and In Vitro

  2022cites this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cites this paper
• Use of Next-Generation Sequencing for Identifying Mitochondrial Disorders

  2022cites this paper
• Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease.

  2022cites this paper
• Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases

  2022cites this paper
• A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model

  2022cites this paper
• Ergothioneine and its prospects as an anti-ageing compound.

  2022cites this paper
• PINK1 regulates mitochondrial fission/fusion and neuroinflammation in β-amyloid-induced Alzheimer's disease models.

  2022cites this paper
• Altered insulin pathway compromises mitochondrial function and quality control both in in vitro and in vivo model systems.

  2021cites this paper
• Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.

  2021cites this paper
• Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and Tauopathies.

  2021cites this paper
• Testosterone ameliorates age-related brain mitochondrial dysfunction

  2021cites this paper
• Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders

  2021cites this paper
• Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease

  2021cites this paper
• Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease

  2021cites this paper
• Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.

  2021cites this paper
• Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases

  2021cites this paper
• Extracellular mitochondria in the cerebrospinal fluid (CSF): potential types and key roles in central nervous system (CNS) physiology and pathogenesis.

  2021cites this paper
• Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases

  2021cites this paper
• Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease

  2021cites this paper
• Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment

  2021cites this paper
• Exercise-Mediated Autophagy and Brain Aging

  2021cites this paper
• New data on well-known drug: focus on meldonium

  2021cites this paper
• Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease

  2021cites this paper
• Protective Effects of a Small Molecule Inhibitor, DDQ Against Amyloid Beta in Alzheimer's Disease.

  2021cites this paper
• Modeling Novel Putative Drugs and Vaccine Candidates against Tick-Borne Pathogens: A Subtractive Proteomics Approach

  2020cites this paper
• 5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice

  2020cites this paper
• SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of resveratrol

  2020cites this paper
• PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

  2020cites this paper
• Amyloid beta (1–42) downregulates adenosine-2b receptors in addition to mitochondrial impairment and cholinergic dysfunction in memory-sensitive mouse brain regions

  2020cites this paper
• Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts

  2020cites this paper
• The Effect of Alpha-Tocopherol on Viability of PC12 Cells during Oxidative Stress and Expression of Genes Encoding Pro- and Anti-Apoptotic Mitochondrial Proteins, SOD2 and Transcription Factors NRF-1, NRF-2 and TFAM

  2020cites this paper
• Intermittent Fasting Enhanced the Cognitive Function in Older Adults with Mild Cognitive Impairment by Inducing Biochemical and Metabolic changes: A 3-Year Progressive Study

  2020cites this paper
• The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases

  2020cites this paper
• Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders

  2020cites this paper
• Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies

  2020cites this paper
• Targeting with nanoparticles for the therapeutic treatment of brain diseases

  2020cites this paper
• Mitophagy in the Retinal Pigment Epithelium of Dry Age-Related Macular Degeneration Investigated in the NFE2L2/PGC-1α-/- Mouse Model

  2020cites this paper
• Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

  2020cites this paper
• Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective

  2020cites this paper
• Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases

  2020cites this paper
• The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy

  2020cites this paper
• Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance

  2020cites this paper
• Drp1 mediates high glucose-induced mitochondrial dysfunction and epithelial-mesenchymal transition in endometrial cancer cells.

  2020cites this paper
• Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases.

  2020cites this paper
• Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease

  2020influential citation
• SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of resveratrol against neurodevelopment damage by fluoride

  2020cites this paper
• Premature synaptic mitochondrial dysfunction in the hippocampus during aging contributes to memory loss

  2020cites this paper
• Synaptic Basis of Alzheimer's Disease: Focus on Synaptic Amyloid Beta, P-Tau and Mitochondria.

  2020cites this paper
• Axonal Transport and Mitochondrial Function in Neurons

  2019cites this paper
• Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease.

  2019cites this paper
• Exploration of age-related mitochondrial dysfunction and the anti-aging effects of resveratrol in zebrafish retina

  2019cites this paper
• Significance of Antioxidants in the Treatment and Prevention of Neurodegenerative Diseases

  2019cites this paper
• Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases

  2019cites this paper
• Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies

  2019cites this paper
• Physiological aging at striatal synapses

  2019cites this paper